DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome

Information source: Hadassah Medical Organization
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Post Thrombotic Syndrome

Intervention: ActiveCare+S.F.T 3rd generation (Device)

Phase: Phase 2

Status: Not yet recruiting

Sponsored by: Hadassah Medical Organization

Official(s) and/or principal investigator(s):
Galia Spectre, MD, Principal Investigator, Affiliation: Hematology departement, Haddash medical Center, Jerusalem, Israel

Overall contact:
Galia Spectre, M.D, Phone: +97226779414, Email: galias@hadassah.org.il

Summary

The use of ActiveCare+S. F.T 3rd generation (an Intermittent Pneumatic Compression Device) will improve quality of life in patients suffering from Post Thrombotic Syndrome compared to compression stockings which is the current gold standard of care.

Clinical Details

Official title: The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome

Study design: Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Primary outcome: Quality of life (Veins-QOL)

Secondary outcome: Villalta Scale

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- patients who have developed post Thrombotic leg symptoms after a deep vein thrombosis

event. Exclusion Criteria:

- admitted patients

- Patients who suffer from peripheral artery disease.

- Patients with an acute deep vein thrombosis.

- s/p leg skin transplant

- Patients with an active leg infection

- Patients who aren't capable of operating the device.

Locations and Contacts

Galia Spectre, M.D, Phone: +97226779414, Email: galias@hadassah.org.il

Hadassah Ein Karem Medical Center, Jerusalem 12000, Israel; Not yet recruiting
Lemberg Hadas, PhD, Phone: +97226777572, Email: lhadas@hadassah.org.il
Galia Spectre, MD, Principal Investigator
Additional Information

Starting date: July 2012
Last updated: July 15, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017